BATF is a basic leucine zipper transcription factor that plays critical roles in immune cell differentiation and function. It acts as part of the AP-1 transcription factor family, forming heterodimers with JUNB and cooperating with IRF4 or IRF8 to regulate gene expression through AICE sequences 1. BATF controls multiple immune cell lineages, including Th17 cell differentiation and regulatory T cell (Treg) activation in tumor microenvironments 2. In CD8+ T cells, BATF functions as a key regulator of exhaustion versus effector states. It can promote T cell exhaustion by upregulating exhaustion-related genes, but paradoxically, BATF overexpression in CAR-T cells enhances antitumor responses by countering exhaustion when cooperating with IRF4 1. Conversely, BATF depletion in CAR-T cells improves antitumor activity by inducing resistance to exhaustion and promoting central memory cell formation 3. BATF also regulates the exit from quiescence in precursor exhausted T cells, with its targets including TCF-1 4. In cancer therapy contexts, BATF expression correlates with clinical outcomes - high BATF expression in Tregs associates with poor prognosis, while BATF modulation in therapeutic T cells can enhance treatment efficacy 25.